2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Abstract Number: 253

Fibromyalgia Patients Are Frequently Thought to be Challenging to Treat-Are They?
Abstract Number: 254

The Lumbar Spine Is Straight in Fibromyalgia Patients
Abstract Number: 255

Interpretation of Proverbs Compared with the Mental Clutter Scale in Fibromyalgia Patients Demonstrates Intact Intellectual Ability Despite the Symptoms of Fibrofog
Abstract Number: 256

The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences
Abstract Number: 257

Argentine Registry of Patients with Fibromyalgia
Abstract Number: 258

Association of Sudoscan Values with Disease Duration in Female Patients with Fibromyalgia
Abstract Number: 259

Prevalence of Attention Deficit Hyperactivity Disorder Among Patients with Fibromyalgia
Abstract Number: 260

Outcome Expectations and Fibromyalgia: Perceived Benefits of Exercise Are Associated with Self-Efficacy and Physical Performance
Abstract Number: 261

Mindfulness Is Associated with Sleep Quality Among Patients with Fibromyalgia
Abstract Number: 262

Shedding Light on Fibromyalgia: Emotional Regulation Processes and Executive Functions Join Together
Abstract Number: 263

Racial Disparities in Total Knee Replacement Failure Are Not Explained By Poverty
Abstract Number: 264

Relationships between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus
Abstract Number: 265

Disparities in Utilization and Direct Costs of Hospitalizations and Emergency Room Visits in SLE: The Georgia Lupus Registry
Abstract Number: 266

Diagnostic Delays and Disparities in Access to Care in Systemic Lupus Erythematosus
Abstract Number: 267

Patterns of Access to Prescription Medications Among Lupus Cases and Controls in the Population-Based Michigan Lupus Epidemiology & Surveillance (MILES) Cohort

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].